title: Inflammation signals airway smooth muscle cell proliferation in asthma pathogenesis.
abstract: BACKGROUND
  Airway inflammation stimulates proliferation of airway smooth muscle cell, which contributes to the development of hyperplasia and hypertrophy of smooth muscle cell. The increase in airway smooth muscle cell mass is believed to be due to an up-regulation of inflammatory mediators in the airway. It is now well recognized that chronic inflammation as well as airway hyper-responsiveness and remodeling of airway during inflammation, are crucial to asthma. Airway hyper-responsiveness is caused by increased cell proliferation or by hypertrophy of airway smooth muscle cell depending on the nature of the inflammatory stimulation. Airway smooth muscle cell proliferation in asthma is regulated by the proinflammatory cytokines including IL-1β and TNF-α. These proinflammatory cytokines have been shown to influence human airway smooth muscle cell proliferation in vitro, which is due to cyclooxygenase-2 expression, production of prostaglandin E2, and increased cAMP levels.
  
  
  CONCLUSIONS
  This review highlights the role of different proinflammatory cytokines in regulating airway smooth muscle cell growth and also focuses on regulation of differential gene expression in airway smooth muscle cell by growth factors and cytokines, also to bestow unique insight into the effects of conventional asthma therapies on airway smooth muscle cell proliferation and development of new therapeutic strategies to control asthma.
authors: Department of Medicine, Stanford University, VAPAHCS, 3801 Miranda Avenue, Building 101, Room B4-105, Palo Alto, California, 94304, USA. afzal@stanford.edu.
authors: Mohammad Afzal
authors: MA
authors: Khan
references: Curr Opin Pharmacol. 2001 Jun;1(3):259-64
references: 11712749
references: Am J Respir Crit Care Med. 2000 May;161(5):1720-45
references: 10806180
references: Respir Med. 2000 Oct;94 Suppl F:S1-2
references: 11059960
references: Thorax. 1999 Sep;54(9):825-57
references: 10456976
references: Ther Clin Risk Manag. 2008 Apr;4(2):363-79
references: 18728834
references: Am J Respir Crit Care Med. 1999 Jun;159(6):1933-42
references: 10351942
references: Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L98-L108
references: 20435686
references: Curr Opin Allergy Clin Immunol. 2009 Feb;9(1):60-6
references: 19532094
references: Respir Med. 2000 Oct;94 Suppl F:S32-33
references: 11059966
references: Allergy. 2007 Jun;62(6):605-10
references: 17508963
references: Int J Chron Obstruct Pulmon Dis. 2010 Oct 05;5:357-66
references: 21037960
references: Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 3):S187-92
references: 9817744
references: Am Rev Respir Dis. 1989 Jan;139(1):242-6
references: 2912345
references: Int Arch Allergy Immunol. 1999 Jun;119(2):120-5
references: 10394103
references: Respir Med. 2000 Sep;94 Suppl D:S1-2
references: 11003166
references: Respir Res. 2003;4:2
references: 12648290
references: Mol Med Today. 1998 Oct;4(10):452-8
references: 9793934
references: Respir Res. 2005 Feb 21;6:19
references: 15723703
references: Br J Pharmacol. 2007 Jan;150(2):192-9
references: 17179953
references: Respir Res. 2001;2(6):333-9
references: 11737932
references: Pharmacol Rev. 1998 Dec;50(4):515-96
references: 9860804
references: Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):257-61
references: 15379593
references: Treat Respir Med. 2006;5(3):159-66
references: 16696586
references: Br J Pharmacol. 2009 Sep;158(1):41-9
references: 19226283
references: Thorax. 1998 Nov;53(11):992-8
references: 10193402
references: Eur Respir J. 2010 Oct;36(4):963-5
references: 20889466
references: Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 3):S123-32
references: 9817735
references: J Immunol. 2001 Jan 1;166(1):155-61
references: 11123288
references: Am J Respir Crit Care Med. 2012 Aug 15;186(4):386; author reply 386-7
references: 22896594
references: Am Rev Respir Dis. 1992 Jun;145(6):1251-8
references: 1595987
references: J Immunol. 2013 Jan 1;190(1):438-46
references: 23197259
references: Br J Pharmacol. 1999 Jul;127(5):1145-50
references: 10455260
references: J Appl Physiol (1985). 1995 May;78(5):1844-52
references: 7649921
references: Respir Res. 2010 Dec 16;11:179
references: 21162738
references: J Immunol. 2000 Jul 15;165(2):716-24
references: 10878344
references: Clin Exp Allergy. 2011 Dec;41(12):1740-6
references: 21762225
references: Am J Respir Cell Mol Biol. 2003 Jul;29(1):19-27
references: 12600820
references: J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1041-53
references: 10856134
references: Br J Pharmacol. 2007 Feb;150(3):313-20
references: 17179941
references: Monaldi Arch Chest Dis. 2008 Jun;69(2):78-80
references: 18837422
references: J Clin Immunol. 2013 Apr;33(3):595-604
references: 23180361
references: Chest. 2008 Apr;133(4):989-98
references: 18398119
references: J Pharmacol Exp Ther. 2007 Mar;320(3):1246-51
references: 17159162
references: J Clin Invest. 1995 Nov;96(5):2393-403
references: 7593627
references: Eur Respir J. 2007 Oct;30(4):691-700
references: 17537774
references: Biologics. 2008 Mar;2(1):67-73
references: 19707429
references: Curr Opin Pharmacol. 2010 Jun;10(3):254-9
references: 20399707
references: Pharmacol Rev. 1997 Dec;49(4):381-402
references: 9443164